These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27604422)

  • 41. The NCCN Guideline Program: a conceptual framework.
    Winn RJ; Botnick WZ
    Oncology (Williston Park); 1997 Nov; 11(11A):25-32. PubMed ID: 9430176
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of medical-decision making and the use of standards of care in oncology.
    Holzer S; Fremgen AM; Hundahl SA; Dudeck J
    Proc AMIA Symp; 2000; ():364-8. PubMed ID: 11079906
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treating chronic myeloid leukaemia: NICE guidance.
    Dowling M; Meenaghan T; Kelly M
    Br J Nurs; 2012 Feb 23-Mar 7; 21(4):S16-7. PubMed ID: 22470902
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Guidelines for gastroenteropancreatic neuroendocrine tumors--what is new? What should be incorporated in daily therapeutic decisions?].
    Grabowski P; Hörsch D
    Z Gastroenterol; 2015 Oct; 53(10):1194-200. PubMed ID: 26480056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [American guideline for geriatric oncology; applicable to Dutch clinical practice?].
    Portielje JEA; Hamaker ME; Maas HAAM; van Leeuwen BL; van den Bos F
    Ned Tijdschr Geneeskd; 2019 Jul; 163():. PubMed ID: 31361408
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ESGO-SIOPE guidelines for the management of adolescents and young adults with non-epithelial ovarian cancers.
    Sessa C; Schneider DT; Planchamp F; Baust K; Braicu EI; Concin N; Godzinski J; McCluggage WG; Orbach D; Pautier P; Peccatori FA; Morice P; Calaminus G
    Lancet Oncol; 2020 Jul; 21(7):e360-e368. PubMed ID: 32615119
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NCCN resource-stratified and harmonized guidelines: A paradigm for optimizing global cancer care.
    Koh WJ; Anderson BO; Carlson RW
    Cancer; 2020 May; 126 Suppl 10():2416-2423. PubMed ID: 32348572
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
    Bagatell R; Park JR; Acharya S; Aldrink J; Allison J; Alva E; Arndt C; Benedetti D; Brown E; Cho S; Church A; Davidoff A; Desai AV; DuBois S; Fair D; Farinhas J; Harrison D; Huang F; Iskander P; Kreissman S; Macy M; Na B; Pashankar F; Pendyala P; Pinto N; Polites S; Rabah R; Shimada H; Slatnick L; Sokol E; Twist C; Vo K; Watt T; Wolden S; Zage P; Schonfeld R; Hang L
    J Natl Compr Canc Netw; 2024 Aug; 22(6):413-433. PubMed ID: 39151455
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NCCN Evidence Blocks.
    Carlson RW; Jonasch E
    J Natl Compr Canc Netw; 2016 May; 14(5 Suppl):616-9. PubMed ID: 27226499
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cancer guideline development in Europe: a survey among ECCO members.
    Schrijvers D; Del Turco MR; Maddock C; Marotti L; Van Hemelryck F
    Eur J Cancer; 2012 Jun; 48(9):1392-400. PubMed ID: 22325839
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Application of hypertension guidelines in clinical practice: implementation of the 2007 ESH/ESC European practice Guidelines in Spain.
    de la Sierra A; Zamorano JL; Ruilope LM
    J Hypertens Suppl; 2009 Jun; 27(3):S27-32. PubMed ID: 19506448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulatory barriers to clinical trial enrollment of adolescent and young adult oncology patients.
    Felgenhauer J; Hooke MC
    Pediatrics; 2014 Jun; 133 Suppl 3():S119-22. PubMed ID: 24918210
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Choosing wisely recommendations in hematology and oncology].
    Krause SW; Neubauer A
    Internist (Berl); 2017 Jun; 58(6):545-549. PubMed ID: 28497377
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Current clinical practice guidelines in type 2 diabetes: how should they be applied in primary care?].
    Navarro Pérez J; Adam AN; Beltrán DO; Guillén VG; Munuera CC
    Aten Primaria; 2010 Sep; 42 Suppl 1(Suppl 1):9-15. PubMed ID: 21074071
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The NCCN guideline for distress management: a case for making distress the sixth vital sign.
    Holland JC; Bultz BD;
    J Natl Compr Canc Netw; 2007 Jan; 5(1):3-7. PubMed ID: 17323529
    [No Abstract]   [Full Text] [Related]  

  • 56. New NCCN Guidelines: Cancer Management in People Living With HIV.
    Suneja G
    J Natl Compr Canc Netw; 2018 May; 16(5S):597-599. PubMed ID: 29784735
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening for psychosocial distress: a national survey of oncologists.
    Pirl WF; Muriel A; Hwang V; Kornblith A; Greer J; Donelan K; Greenberg DB; Temel J; Schapira L
    J Support Oncol; 2007; 5(10):499-504. PubMed ID: 18240673
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Institutional validation of breast cancer treatment guidelines.
    Minter RM; Spengler KK; Topping DP; Flug R; Copeland EM; Lind DS
    J Surg Res; 2001 Sep; 100(1):106-9. PubMed ID: 11516212
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Measuring the evidence that informs clinical treatment recommendations.
    Vandergrift JL
    J Natl Compr Canc Netw; 2012 May; 10(5):678-80. PubMed ID: 22570296
    [No Abstract]   [Full Text] [Related]  

  • 60. Evaluation of preliminary NCCN guidelines by external review.
    Winn RJ; Botnick W; Bitsura JA
    Oncology (Williston Park); 1996 Nov; 10(11 Suppl):311-5. PubMed ID: 8953611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.